Presentation Information
[3S14a-04]DXd ADC Technology: Advancements in Daiichi Sankyo's Approach to Anti-Cancer Therapeutics
○Kento Tanaka (Daiichi Sankyo Co., Ltd.)
キーテクノロジー:Antibody Drug Conjugate
Keywords:
Antibody Drug Conjugate
Password required to view
Comment
To browse or post comments, you must log in.Log in
